Skip to content

Improving Outcomes for Juvenile Idiopathic Arthritis

Improving Outcomes for Children Newly Diagnosed With Juvenile Idiopathic Arthritis Through a Structured Support Program (JASP-1) - A Longitudinal Register Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07659223
Enrollment
116
Registered
2026-06-22
Start date
2019-08-15
Completion date
2026-02-19
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopahtic Arthritis

Keywords

JIA, Support-program,, Register study

Brief summary

Children and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year after diagnosis. However, little is known about how a support program like JASP-1 can influence outcomes. Therefore, this study aimed to longitudinally examine registry data from children who participated in JASP 1 and to compare the outcomes with registry data from a matched control group.

Detailed description

Methods: The study is a longitudinal register study with data from the Swedish Pediatric Rheumatology Quality Register (PedSRQ). Data included outcome measures from the child and/or the parents as well as clinical information's from the physicians.

Interventions

BEHAVIORALThe intervention was a one year support program JASP-1

Seven structured visits with a patient-and family-centered approach was used in the JASP-1 program, in which children newly diagnosed with JIA and their parents were invited to participate in.

Sponsors

Region Stockholm
Lead SponsorOTHER_GOV
Karolinska University Hospital
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The intervention JASP-1 is a support program consisting of seven structured visits the first year following JIA diagnosis

Eligibility

Sex/Gender
ALL
Age
0 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* For the JASP-1: Diagnosed with JIA and have completed the JASP-1. * For the control group: Diagnosed with JIA at the same clinic as above

Exclusion criteria

* No JIA diagnosis * Change of diagnose during the year * Do not understand or speak Swedish

Design outcomes

Primary

MeasureTime frameDescription
CHAQ, Disabkids, Physicians global assessmentFor one year following JIA diagnosis56 children received JASP-1and was on 3 timepoints compared with 60 children matched in disease, gender and age.The measures compared is CHAQ including pain, disease impact on overall well-being and school attendance, DISABKIDS, JADAS-71, Physicians global assessment, Number of active joints, Number of joint injections and Pharmacological treatment. Outcomes at 12 months, were analyzed using the non parametric Mann-Whitney U test. For categorical variables differences were analyzed using the chi-square test to compare proportions. Repeated measurement ANOVA was used for calculating differences over time between the two groups. P value \< 0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics for Windows, version 31.
CHAQAssessed several times during the first year after diagnosis. Values from 0-3Childhood Health Assessment Queationnaire
DisabkidsAssessed at 3 timepoints during the first year, values between 0-100Health Related Quality of Life
Phycisians global assessmentDuring the first year after diagnosisAssessed at 3 timepoint during the first year after diagnosis. Valued on a VAS scale 0-10

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026